DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Priscilla Chan - 1 Mark Zuckerberg - 1 it'll - 1 Chan - 1 Zuckerberg - 1 I'm - 1 Anne Carpenter - 1 Carpenter - 1
Top related locs:
Wall Silicon San Francisco
Top related orgs:
Service - 1 Broad Institute of Harvard - 1 MIT - 1 Chan Zuckerberg Initiative - 1 San - 1 Engadget - 1

Search resuls for: "Broad Institute of Harvard"


2 mentions found


☆ Mark Zuckerberg and Priscilla Chan announced they're building a computing system to help eliminate human disease by 2100, but costs may be hefty
  + stars: | 2023-09-22 | by ( Maiya Focht | ) www.businessinsider.com   time to read: +5 min
Priscilla Chan and husband Mark Zuckerberg announced plans to eradicate human disease by 2100. One researcher's excited by the potential, but said it'll likely take lots of time and money to complete. The data could be used to make new discoveries that completely eliminate human disease, Chan and Zuckerberg said in a statement. The Chan Zuckerberg Initiative, the couple's LLC, told The Register that they plan to have their product running by 2024. "AlphaFold has sparked a wave of innovation by showing people what's possible," Chris Bahl, the chief scientist at AI Proteins, previously told Insider.
Persons: Priscilla Chan, Mark Zuckerberg, it'll, Chan, Zuckerberg, I'm, Anne Carpenter, Carpenter, Chan Zuckerberg, CZI, Forbes, AlphaFold, Chris Bahl, Jeff MacGregor Organizations: Service, Broad Institute of Harvard, MIT, Chan Zuckerberg Initiative, San, Engadget Locations: Wall, Silicon, San Francisco
☆ CRISPR pioneer Feng Zhang's secretive gene-editing startup has hired ex-Alnylam leaders as CEO and chair
  + stars: | 2023-02-07 | by ( Andrew Dunn | ) www.businessinsider.com   time to read: +4 min
The gene-editing startup Aera has hired biotech vets Akin Akinc as CEO and John Maraganore as chairman. CRISPR pioneer Feng Zhang's newest gene-editing venture has attracted two longtime leaders of the biotech giant Alnylam Pharmaceuticals, Insider has learned. Former Alnylam CEO John Maraganore is chairman of Aera. The SEND technology could allow gene-editing technology to treat more diseases. Based on Zhang's SEND research, Aera hopes to deliver gene-editing tools to more organs, ultimately expanding the number of diseases CRISPR can impact.
0 next >>
Total: 2